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ABSTRACT
Chronic cough has been reported to be the fifth most com-
mon complaint seen by primary care physicians in the world,
the third in Italy. Chronic cough in non-smoking, non-treated
with ACE-inhibitor adults with normal chest radiogram could
be a symptom of asthma and can be sub-classified into:
cough-variant asthma, atopic cough, and eosinophilic bron-
chitis. This review discusses the differential diagnosis of these
three disorders. 
Keywords: Atopic cough, bronchial hyperresponsiveness,
cough-variant asthma, eosinophilic bronchitis.
RIASSUNTO 
La tosse cronica è la quinta causa che induce a consultare il
proprio medico di famiglia nel mondo, in Italia è la terza. La
tosse cronica in un adulto non fumatore che non assume ACE-
inibitori ed ha una Rx torace nella norma può essere un sinto-
mo indicatore di asma in una delle sue tre varianti: asma va-
riante con tosse, tosse atopica e bronchite eosinofila. La dia-
gnosi differenziale di queste tre patologie è oggetto di questa
rassegna.
Parole chiave: Asma variante con tosse, bronchite eosinofila,
iperreattività bronchiale, tosse atopica.
In some patients cough is a chronic unremitting
symptom leading to a marked decrement in quality
of life [1,2]. Chronic cough has been reported to be
the fifth most common complaint seen by primary
care physicians [3]. For instance, in USA up to 38%
of a pulmonologist’s outpatient practice is account-
ed for by persistently troublesome chronic cough
[4]. In Japan, cough is the most frequent reason
(11.7% of all) why patients visit clinics [5]. In Italy,
cough is the third most common cause of medical
visits with about 25 million consultancies for cough
per year of which 5 million for the acute problem
and 2 million for the chronic one (Dal Negro, per-
sonal communication). According to questionnaire
surveys, the prevalence of chronic cough in the
general population, including children, may vary
from 9 to 33% [6]. Chronic cough is present in old-
er subjects as may be seen from the average age of
patients seen in cough clinics (Table I).
The most common causes worldwide of chronic
cough in non-smoking, non-treated with ACE-in-
hibitor adults with normal chest radiogram include
the upper airway cough syndrome (UACS), gastro-
esophageal reflux disease (GERD) and asthma syn-
dromes [4,7-15]. This indicates a group of related
airway disorders including the “classic” asthma, the
so-called cough variant asthma, nonasthmatic
eosinophilic bronchitis (NAEB), and atopic cough.
However, even if the guidelines on cough diagnosis
and management [16-18] are followed in detail, the
cause of chronic cough may remain unexplained in
up to 33-46% of cases [6,19]. The prevalence of
UACS, GERD and asthma syndromes varies in dif-
ferent reports [4,7-15]. This suggests the necessity of
further examination to elucidate cough mecha-
nisms and etiology [20]. The differences in preva-
lence may depend upon racial and life style differ-
ences, access to specialists or differences in the def-
inition of some cough causes [21,22]. For instance,
in the United Kingdom and Australia the two most
common causes of cough are rhinitis for both (24%
and 93% respectively), followed by asthma in UK
(17.6%) and GERD in Australia (70%) [11,23]. In
Turkey, eosinophilic bronchitis is the cause of
chronic cough in 33.3% of patients, while post-
nasal drip syndrome and GERD are each responsi-
ble for chronic cough in 22.2% of patients [24]. In
Japan, cough variant asthma and atopic cough are
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major causes of isolated chronic non-productive
cough [25]. Gastro-esophageal reflux-associated
cough and post-nasal drip-induced cough, which
are major causes of chronic cough in Western
countries [26], are very rare in Japan [27]. 
Chronic cough can arise in asthma in various clini-
cal settings, and is not always associated with air-
flow obstruction, wheezing or dyspnea. In addition,
asthma may predominantly present with cough,
which is often nocturnal; the diagnosis is supported
by the presence of bronchial hyper-responsiveness
[28]. Elderly people with asthma can also present
with a history of chronic cough, with little or no
wheezing. Cough is often the symptom most report-
TABLE I: COMMONEST CAUSES OF CHRONIC COUGH IN PATIENTS INVESTIGATED IN SPECIALIST CLINICS  
Author Patients' mean age  Diagnosis (% of total)
in years (range)
Asthma syndrome GERD Rhinitis Most common other causes
Irwin et al. 1981 [38] 50.3 (17-88) 25 10 29 Chronic bronchitis (12)
Poe et al. 1982 [39] ? (15-89) 36 0 8 Postinfectious (27)
Poe et al. 1989 [7] 44.8 (19-79) 35 5 26 Idiopathic (12)
Irwin et al. 1990 [4] 51 (6-83) 24 21 41 Chronic bronchitis (5)
Hoffstein 1994 [40] 47 25 24 26 Postinfectious (21)
O’Connell et al. 1994 [41] 49 (19-83) 6 10 13 Idiopathic (22)
Smyrnios et al. 1995 [42] 58 (18-86) 24 15 40 Chronic bronchitis (11)
Mello et al. 1996 [43] 53.1 (15-83) 14 40 38 Bronchiectasis (4)
Marchesani et al. 1998 [44] 51 14 5 56 Chronic bronchitis (16)
McGarvey et al. 1998 [10] 47.5 (18-77) 23 19 21 Idiopathic (18)
Palombini et al. 1999 [13] 57 (15-81) 59 41 58 Bronchiectasis (18)
Brightling et al. 1999 [11] * 31 8 24 Postviral (13)
Definition of abbreviation: GERD, gastroesophageal reflux disease.
*No figures given for the total sample but mean age of 12/91 patients with eosinophilic bronchitis
given as 52 (28-76) years.
TABLE II: COUGH CAUSED BY EOSINOPHILIC AIRWAY DISEASES  
Asthma Cough variant Atopic Eosinophilic
asthma cough bronchitis
Symptoms Cough, breathlessness, Cough only Cough only Cough and sputum
wheeze
Atopy Common Common Common As in general population
Variable airflow obstruction + ± - -
Airway hyper-responsiveness + + - -
Capsaicin cough hyper-responsiveness ± ± - +
Bronchodilator response + + - -
Corticosteroid response + + + +
Response to H1 antagonist ± ± + NK
Progression to asthma n/a 30% rare 10%
Sputum eosinophilia (> 3%) Frequent Frequent Frequent Always (by definition)
Submucosal eosinophils ↑ ↑ ↑ ↑
BAL eosinophilia ↑ ↑ ↓ ↑
Mast cells in ASM ↑ ↓ NK ↓
Basement membrane thickness ↑ ↑ NK ↑
Definition of abbreviations: ASM, airway smooth muscle; BAL, bronchoalveolar lavage; n/a, not
applicable; NK, not known.
+ = often present. 
± = sometimes present.
− = not present.
↑ = increased.
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ed by patients with chronic asthma, despite the fact
they have achieved good asthma control with in-
haled corticosteroids [29]. Finally, cough can be the
first sign of worsening of asthma; doctors should
look for a fall in early morning peak flows [30]. 
As mentioned above, three asthma-related condi-
tions, which are accompanied by chronic cough,
have been described: cough-variant asthma, atopic
cough, and eosinophilic bronchitis (Table II) [30]. 
Whether atopic cough represents a self-standing air-
way disease is still the object of debate [31]. In
1992 Fujimura and others proposed the existence of
a bronchodilator-resistant non productive chronic
cough associated with atopy which they termed
“atopic cough” [32]. According to the authors [31],
the pathological characteristics of atopic cough include
eosinophilic tracheobronchitis without broncho -
alveolar lavage (BAL) eosinophilia, and the physio-
logical characteristics of atopic cough include
cough hypersensitivity without bronchial hyper -
responsiveness (BHR) [33]. Conversely, cough vari-
ant asthma [34] appears to be similar to asthma,
with mild BHR and eosinophilic inflammation of
central and peripheral airways, and a cough respon-
sive to bronchodilator treatment [28].
Until the 1970s cough was commonly associated
with episodic wheezing and dyspnea in sympto-
matic asthmatic patients. Corrao et al. [28] studied
six patients with chronic persistent cough as the
sole manifestation of bronchial asthma as diag-
nosed according to the criteria of the American
Thoracic Society [35]: all had persistence for an aver-
age of six months, inducible diffuse airway broncho -
constriction and disappearance of cough with spe-
cific bronchodilator therapy. The return of cough
when bronchodilators were discontinued, the dis-
appearance of cough with the re-institution of this
medication and the subsequent development of
wheezing in two patients further supported the au-
thors’ contention that these cases represented a
variant group of asthma [28]. Some years later
Braman and Corrao [3] re-studied patients diag-
nosed with cough variant asthma and found that
37% of these patients had developed intermittent
wheezing. As nearly 30% of patients with cough
variant asthma have been found to develop typical
asthma, cough variant asthma has been considered
a precursor of typical asthma. However, the evolu-
tion of atopic cough, particularly with regard to its
progression to typical asthma, has not been eluci-
dated [31]. Determining whether atopic cough is a
precursor of asthma may be important [36] in terms
of the possibility of early intervention in asthma
therapy.
In 2003 Fujimura et al. [31] examined retrospec-
tively the onset of typical asthma, defined as
wheezing and/or a dyspneic attack responding to
inhaled β2-agonists, in 82 patients with atopic
cough (with probable or definite diagnosis) and in
55 patients affected by cough variant asthma with
or without long term treatment with inhaled
steroids. The median follow up period for patients
with atopic cough and cough variant asthma was
4.8 and 3.7 years, respectively.
The diagnosis of atopic cough was made according
to the following criteria proposed by the Japanese
Cough Research Society:
1. Non-productive cough lasting for more than 8
weeks without wheezing or dyspnea.
2. Presence of one or more findings indicative of an
atopic constitution, including a past history
and/or complications of allergic diseases exclud-
ing asthma, peripheral blood eosinophilia (≥ 6%
or ≥ 400 cells/mL), raised total IgE level in serum
(≥ 200 IU/mL), positive specific IgE antibody to
aeroallergens and positive allergen skin test and/or
induced sputum eosinophilia (≥ 2.5%).
3. No bronchial reversibility, defined as less than a
10% increase in forced expiratory volume in 1
sec (FEV1) after inhalation of 300 µg salbutamol
sulphate.
4. Normal bronchial responsiveness (positive re-
sponsiveness being the provocative concentra-
tion of methacholine causing a 20% fall in FEV1
(PC20) < 10 mg/mL). 
5. Increased cough reflex sensitivity (capsaicin con-
centration eliciting five or more coughs (C5) ≤ 3.9
mmol/L).
6. Cough resistant to bronchodilator therapy (oral
clenbuterol 40 mg/day plus inhaled procaterol or
salbutamol at bedtime and on demand for ≥ 1
week).
7. No abnormal findings indicative of cough etiolo-
gy on chest X-ray.
8. Normal FEV1 (≥ 80% of predicted value), forced
vital capacity (FVC) (≥ 80% of predicted value),
and FEV1/FVC ratio (≥ 70%). 
When all criteria were satisfied, a definite diagnosis
of atopic cough was made. If one or more criteria
were not satisfied (or assessed), a diagnosis of prob-
able atopic cough was made when all of the follow-
ing were present: i) non-productive cough lasting
more than 8 weeks without wheezing or dyspnea;
ii) cough resistant to bronchodilator therapy; iii)
presence of one or more findings indicative of
atopic constitution as a global feature described
above and/or induced sputum eosinophilia (≥
2.5%); and iv) complete relief of cough after treat-
ment with histamine H1-antagonists and/or corti-
costeroid therapy.
The complete relief of cough within 2 months of
treatment was an important factor in making a prob-
able diagnosis of atopic cough even if 2–3 weeks of
oral corticosteroids were required for severe patients.
The diagnosis of cough variant asthma was made
according to the following criteria proposed by the
Japanese Cough Research Society: i) isolated chron-
ic non-productive cough lasting more than 8 weeks;
ii) absence of a history of wheeze or dyspnea, and
no adventitious lung sounds on physical examina-
tion; iii) absence of postnasal drip to account for the
cough; iv) FEV1, FVC, and FEV1/FVC ratio within
normal limits; v) presence of bronchial hyper -
responsiveness (PC20 < 10 mg/mL); vi) cough reflex
sensitivity within normal limits (C5 > 3.9 mmol/L);





























03 ogy on chest radiograph; and viii) relief of cough
with bronchodilator therapy.
The efficacy of bronchodilator therapy was assessed
according to the following criteria: i) ‘excellent’
when cough was totally resolved; ii) ‘good’ when
sleep and daytime quality of life were improved; iii)
‘fairly good’ when severity and frequency of cough
were somewhat decreased; and iv) ‘poor’ when the
cough was unchanged. An assessment of ‘excellent’
or ‘good’ was judged as effective. When all criteria
were satisfied, a definite diagnosis of cough variant
asthma was made. If one or more criteria were not
satisfied (or assessed), a diagnosis of probable
cough variant asthma was made when all of the fol-
lowing were present: i) cough without wheezing last-
ing 8 weeks or more and no wheezes on auscultation;
ii) no upper respiratory tract infection within 8 weeks;
and iii) relief of cough with bronchodilator therapy.
The results showed that in patients with cough vari-
ant asthma the onset of typical asthma occurred in
5.7% of patients in the group treated with inhaled
corticosteroid therapy and in 30% of patients in the
group not treated. In patients with atopic cough the
onset of typical asthma was confirmed in only 1.2%
of the total. The onset of typical asthma was thus
significantly less prevalent in patients with atopic
cough than in those with cough variant asthma. In
addition, long term inhaled steroids significantly
decreased the development of typical asthma in pa-
tients with cough variant asthma. If mild asthma
benefits from early intervention with long term in-
haled steroids, it will be also useful for cough vari-
ant asthma. As atopic cough differs from cough
variant asthma with regard to both outcome and
pathophysiological features, the authors recom-
mended that atopic cough be recognized as a new
clinical entity characterized by isolated chronic
non-productive cough [31].
Morice and McGarvey [37] in a letter to Fujimura
and collegues expressed their dismay at reading the
paper [31]. The diagnosis of “atopic cough”, they
claimed, would succeed only in adding further un-
necessary complexity to the cough-related condi-
tions [37]. The evidence to support a new clinical
entity “atopic cough” they felt was tenuous and fur-
ther hampered by the extremely vague term “prob-
able atopic cough”, that merely described atopic in-
dividuals with cough predominant asthma. Such di-
agnostic imprecision may yet have therapeutic con-
sequences but Morice and McGarvey claimed that
the authors did not provide sufficient information in
the paper to conclude that these patients had failed
to respond to steroids, and claimed that the re-
sponse to bronchodilators was tested in neither a
randomized nor a controlled way [37]. The “ab-
sence of transformation to typical asthma” was con-
sidered too heavily to differentiate atopic cough
from asthmatic cough [37]. The lack of progression
to typical asthma is well described both in atopic
cough and in cough variant asthma, so it cannot be
used to support the proposition that atopic cough is
unique [37]. Summing up, Morice and McGarvey
believe their clinical understanding of asthmatic
cough is enhanced by the recognition that an indi-
vidual patient may show different features of the
disease process. The unnecessary subdivision into
an arbitrarily defined “disease” such as atopic
cough (or, indeed, eosinophilic bronchitis) is not
helpful either diagnostically or therapeutically.
In conclusion, the confusion or lack of consensus in
cough-related disorders may be affecting the etiolo-
gy of chronic cough reported from various countries
[21]. Issues such as site of inflammation, mediators
involved, and allergens in “atopic” causes for these
entities remain to be clarified in more detail in fu-
ture studies [45].
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